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Abstract
Background: Small-for-gestational-age in infancy is a known risk factor not only for short-term prognosis but also
for several long-term outcomes, such as neurological and metabolic disorders in adulthood. Previous research has
shown that severe nausea and vomiting in early pregnancy (NVP) and hyperemesis gravidarum, which is an
extreme form of NVP, represent risk factors for small-for-gestational-age birth. However, there is no clear consensus
on this association. Thus, in the present study, we investigated the correlation between hyperemesis gravidarum and
NVP on the one hand, and infant birth weight on the other, using data from the Japan Environment and Children’s
Study (JECS).
Methods: The data utilized in the present study were obtained from the JECS, an ongoing cohort study that began in
January 2011. Our sample size was 8635 parent–child pairs. The presence or absence of severe NVP, hyperemesis
gravidarum, and potential confounding factors were noted. A multivariable regression analysis was used to estimate
risks for small-for-gestational-age birth, and the results were expressed as risk ratios and 95 % confidence intervals.
Results: The risk ratios of small-for-gestational-age birth (95 % confidence interval) for mothers with severe NVP and
those with hyperemesis gravidarum were 0.86 (0.62–1.19) and 0.81 (0.39–1.66), respectively, which represents
a non-significant result.
Conclusions: In our analysis of JECS data, neither severe NVP nor hyperemesis gravidarum was associated
with increased risk for small-for-gestational-age birth.
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Background
There is a high incidence of nausea and vomiting in early
pregnancy (NVP), reported at 35–91 % [1–4]. NVP can
become severe in 0.3–3.6 % of cases, with hyperemesis
gravidarum (HG) as an extreme form of NVP that is asso-
ciated with weight loss [1–4]. The incidence of HG varies
by country, and was reported at nearly 3.6 % in Japan [4].
The condition known as small-for-gestational-age
(SGA) is a concern in infants, as it carries with it a
multitude of risks, including a poorer life prognosis,
neurological disorders, and metabolic diseases during
adulthood [5, 6]. SGA is defined using the 10th percent-
ile for birth weight as the cutoff value [7, 8].
There are many risk factors for SGA, but most of
these are not well understood. Extreme NVP may result
in poor health during pregnancy, which can influence
the prognosis of fetuses [9, 10], possibly leading to an in-
crease in the risk of SGA birth [9, 11–13].
Recent systematic reviews suggest that HG increases
the risk of low birth weight and SGA by 42 and 28 %, re-
spectively [12]. Furthermore, severe maternal weight loss
in early pregnancy, typically linked with extreme NVP,
has been linked with growth restriction [9]. However,
other reports have suggested that HG does not influence
growth restriction [14, 15], birth weight [11, 16, 17], or
risk for SGA [18]. Thus, there is as yet no clear consen-
sus on this issue [11, 16, 17].
In the present study, we investigated the effect of se-
vere NVP and HG (extreme NVP), with respect to the
risk for SGA birth in the Japanese population.
Methods
The data used in this study were obtained from The
Japan Environment and Children’s Study (JECS), which
is an ongoing cohort study that began in January 2011.
The objective of the JECS is to determine the effect of
environmental factors on children’s health.
More than 100,000 pregnant women were recruited
over a period of approximately 3 years. The recruitment
period ended in March 2014.
The pregnant women lived in one of the 15 study re-
gions included in the JECS. The 15 regions were se-
lected to cover wide geographical areas in Japan. We
made contact with as many of these expecting mothers
as possible. Either or both of the following two recruit-
ment protocols were applied: 1) recruitment at the time
of the first prenatal examination at cooperating health
care providers, i.e., obstetric facilities (provider-medi-
ated community-based recruitment), and/or 2) recruit-
ment at local government offices issuing pregnancy
journals, namely the Mother-Child Health Handbook,
which is an official complimentary booklet that all
expecting mothers in Japan are given when they
become pregnant in order to receive municipal services
for pregnancy, delivery, and childcare.
The JECS protocol was approved by the Review Board
on epidemiological studies of the Ministry of the Envir-
onment, and by the Ethics Committees of all participat-
ing institutions. The JECS is conducted in accordance
with the Helsinki Declaration and other nationally valid
regulations, and with written informed consent from all
participants. However, those who had difficulty filling
out the questionnaire in Japanese or had other unavoid-
able circumstances preventing them from participating
in the survey, such as being in their hometown at the time
of childbirth, were excluded from the analysis [19, 20].
As of the end of 2011, a total of 9646 participants
had successful childbirths. After excluding cases with
missing data and preterm births, we analyzed the re-
cords of the remaining 8631 women who had single,
full-term (37–42 weeks) pregnancies (Fig. 1). The present
study is based on the data set “jecs-ag-ai-20131008”,
which was released in October 2013.
Follow-up was conducted using a self-administered
questionnaire. The questionnaires were completed dur-
ing the first and second trimesters, as well as at 1 month
postpartum. We obtained medical information from
medical records transferred for examinations during the
same time periods.
The questionnaires were designed to collect information
on pregnancy and medical history as well as on confound-
ing and modifying factors, such as social and lifestyle fac-
tors. We collected information on birth, such as the birth
weight, from the transferred medical records.
The following question was included in the question-
naire for the second trimester to determine the status of
HG: “Did you have morning sickness from conception
Fig. 1 Participant inclusion flowchart
Morokuma et al. BMC Pregnancy and Childbirth  (2016) 16:247 Page 2 of 7
until about week 12 of the pregnancy?” (1 = no, 2 = just
nausea, 3 = vomiting, but was able to eat, 4 = vomiting,
and was unable to eat). We thus defined the following
groups for analysis: the “food intake group”, which in-
cluded the women who answered 1, 2, or 3; the “no
food” or severe NVP group, which included the women
who answered 4; and the HG group, which was a subset
of participants from the NVP group that included
women with severe NVP and weight loss of >5 % from
pre-pregnant weight in the first trimester.
The participants underwent ultrasound examinations
during the first trimester, and these results were used to
determine the expected date of delivery if there was
more than a 7-day difference between this date and the
date calculated from the last menstrual period. Birth
weight was transferred from medical records, and SGA
was concluded if the weight was below the 10th percent-
ile according to primiparous and multiparous birth size
standards for both genders by gestational age in Japanese
neonates [21].
The following covariates were included in the ques-
tionnaire for the first trimester: maternal age, pre-
pregnancy body mass index (BMI), parity, smoking
status, and alcohol consumption; the covariates of educa-
tion and income were included in the questionnaire for
the second trimester; the covariates of weight gain during
pregnancy were calculated based on information from
medical records.
Statistical analysis
Based on the records of mothers of singletons delivered
at full term, we evaluated the relationship between SGA
and NVP, HG, factors related to the patient’s back-
ground, and social factors. Continuous variables were
expressed as mean ± standard deviation (SD). We calcu-
lated crude relative risk ratios (RRs) and 95 % confi-
dence intervals (CIs) using the chi-squared test. The
interrelationship between patient background, social
factors, and birth weight was evaluated by univariate
analysis. Covariates of maternal age, pre-pregnancy
BMI, weight gain during pregnancy, gestational age at
birth, smoking, alcohol consumption, education, and
income were included in the calculation of adjusted
risk ratios. The adjusted relative RR was calculated
using a log-binomial regression model. All statistical
analyses were performed using SAS version 9.3 (SAS
Institute Inc., Cary, NC, USA).
Results
There were 880 patients (10.2 %) who experienced se-
vere NVP, and 136 patients (1.6 %) who experienced
HG. The mean age of participants, weeks of pregnancy
at birth, and birth weight were 30.6 ± 5.02 years, 39.0 ±
1.14 weeks, and 3050.0 ± 371.32 g, respectively. The
results of the univariate analysis are shown in Table 1.
The adjusted risk ratios for mothers with a pre-
pregnancy BMI of <18.5 kg/m2, mothers with a weight
gain of <7 kg during pregnancy, and those who smoked
were 1.58 (95 % CI, 1.32–1.90), 1.28 (95 % CI, 1.05–
1.55), and 1.48 (95 % CI, 1.11–1.97), respectively, in-
dicating a slightly higher risk of SGA birth. Moreover,
the risk ratio was 0.60 (95 % CI, 0.43–0.85) for
mothers with a pre-pregnancy BMI of >25 kg/m2, and
0.52 (95 % CI, 0.41–0.66) for mothers with a weight gain
of >12 kg during pregnancy, indicating a lower risk of
SGA birth.
Tables 2 and 3 show the crude and adjusted risk ratios
calculated using covariates such as the mother’s age, pre-
pregnancy BMI, weight gain during pregnancy, parity,
smoking and drinking, education, and income, to deter-
mine the effect of severe NVP or HG on the risk of SGA.
The risk ratios for mothers with severe NVP and those
with HG were 0.86 (95 % CI, 0.62–1.19) and 0.81 (95 %
CI, 0.39–1.66), respectively, indicating a non-significant
effect of NVP or HG on the risk for SGA birth.
Discussion
In our analysis of JECS data, neither NVP nor HG was
associated with the risk for SGA birth. The incidence of
HG was 1.6 %, which is lower than the 3.6 % incidence
reported by the latest study in the general Japanese
population [4], but within the range of 0.3–2.0 % re-
ported by other studies [1–3]. In addition, the partici-
pants in our study reported an incidence of NVP of
10.2 %, which is lower than the 33 % incidence reported
by Chortatos et al. [22]; the difference is likely related to
the fact that we defined NVP based on self-reported ac-
counts of reduced food intake.
Our study has a methodological limitation, because
data regarding the severity of NVP were collected via
a self-response questionnaire, while data regarding
maternal weight loss were collected from the Mother-
Child Health Handbooks and hospital records, and it is
unknown whether participants required hospitalization
for severe HG, how long severe NVP or HG per-
sisted, and whether the condition reflected in the bio-
chemical parameters.
Another limitation is the fact that the questionnaire
was applied in the second trimester, but the questions
themselves referred to early pregnancy; thus, there might
be the risk of recall bias, resulting in an overestimation
of the severity of NVP. However, we do not believe that
this effect was significant, because the questionnaire was
applied during the pregnancy period; moreover, the def-
inition of HG was based on independent records of ma-
ternal weight loss.
A further limitation is related to the fact that our re-
sults were obtained based on the data regarding 136
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cases of HG, which may be considered a small num-
ber in the context of an epidemiologic study. None-
theless, given that the incidence of HG is expected
to be under 2 %, and there is yet no consensus re-
garding the influence of HG on the risk for SGA
birth, we believe that a sample size of 136 cases can
ensure sufficient power to detect relevant trends, as
some reports indicate that HG may increase the risk
for SGA birth by up to 40 %; moreover, even if the
power is low, the potential tendencies should be
Table 1 Characteristics of all parent-child pairs included in this study (N = 8631)
No. (%) Missing data No. of non-SGA births No. of SGA births % SGA RR for SGA birth 95 % CI
Mother’s age (years)
19 or less 103 1.3 13 85 5 5.6 0.72 0.30 1.69
20–34a 5893 75.6 372 5093 428 7.8 (1.0)
35 or more 1801 23.1 83 1610 108 6.3 0.81 0.66 0.99
missing 834 15 774 45
Mother’s education
> 12 years 5227 62.8 320 4558 349 7.1 0.97 0.82 1.14
≤ 12 yearsa 3098 37.2 135 2745 218 7.4 (1.0)
missing 306 28 259 19
Parity
0a 3150 38.4 18 2893 239 7.6 (1.0)
≥ 1 5043 61.6 27 4669 347 6.9 0.91 0.77 1.06
missing 438 438 - -
Pre-pregnancy body mass index
< 18.5 1363 16.2 69 1153 141 10.9 1.58 1.32 1.90
18.5–24.9a 6212 73.7 346 5462 404 6.9 (1.0)
≥ 25 856 10.2 34 788 34 4.1 0.60 0.43 0.85
missing 200 34 159 7
Weight gain during pregnancy
< 7 kg 1354 17.7 64 1162 128 9.9 1.28 1.05 1.55
7–12 kga 4104 53.6 244 3560 300 7.8 (1.0)
> 12 kg 2198 28.7 102 2011 85 4.1 0.52 0.41 0.66
missing 975 73 829 73
Income
< 4 million yen 3266 41.1 183 2854 229 7.4 1.07 0.90 1.27
4–8 million yena 3836 48.3 208 3375 253 7.0 (1.0)
> 8 million yen 843 10.6 53 732 58 7.3 1.05 0.80 1.39
missing 686 39 601 46
Smoked during pregnancy
Noa 7991 94.5 455 7013 523 6.9 (1.0)
Yes 462 5.5 15 401 46 10.3 1.48 1.11 1.97
missing 178 13 148 17
Alcohol intake during pregnancy
Noa 7654 90.2 435 6710 509 7.1 (1.0)
Yes 835 9.8 38 732 65 8.2 1.16 0.90 1.48
missing 142 10 120 12
Data extracted from the Japan Environment and Children’s Study
No. number, SGA small-for-gestational-age, RR risk ratio, CI confidence interval
aUsed as reference in the calculation of risk ratios
Morokuma et al. BMC Pregnancy and Childbirth  (2016) 16:247 Page 4 of 7
recognizable, because the confidence interval for our
results is narrow.
Finally, another limitation of the study is related to
the fact that the incidence of SGA birth in the group
of mothers for whom weight gain information was
missing was relatively high. Unfortunately, the reason
for this higher incidence of SGA births cannot be
assessed based on the data available to us. While it is
possible that the characteristics of the mothers ex-
cluded from the study because of missing information
on weight gain may have an influence on the results,
we do not expect this influence to extend to the con-
clusions of our study.
Previous research demonstrating HG as a risk factor
for SGA includes a study by Bailit et al., which
showed that neonates born from mothers requiring
hospitalization for HG were 125 g smaller compared
to those born from mothers without such symptoms
[11]. However, that study employed hospital admis-
sion rates for defining HG, which is a more subjective
measure than is maternal weight loss. On the other
hand, in other studies, which reported that HG leads
to SGA birth [9, 10], the HG definition was based on
maternal weight loss throughout pregnancy period;
however, it was unclear whether the weight change
was due to HG. In our study, the HG group included
mothers with severe NVP (vomiting and not able to
eat) and with weight loss of >5 % from pre-pregnant
weight in the first trimester. Based on such a strict
definition, our results showed that neither severe nor
extreme NVP (i.e., HG) represented a risk factor for
SGA birth.
The recent Norwegian Mother and Child Cohort
Study reported that HG-exposed babies had slightly re-
duced birthweight, but there were no association be-
tween HG and SGA birth [18, 23], although it should be
noted that no adjustment for weight gain was made,
while adjusting for smoking status slightly increased the
effect of HG. Further reports have suggested that HG
does not influence birth weight [11, 16, 17]. Our results
are in agreement with the findings of the studies that re-
ported no relationship between HG and SGA birth;
nevertheless, the relevance of adjusting for weight gain
when evaluating the influence of HG should be noted,
implying that the risk for SGA birth is reduced when
sufficient weight gain is ensured during pregnancy.
It is important to note that both sets of studies (i.e.,
those concluding an effect and those concluding a lack of
an effect) studied patients who required hospitalization.
Even under these conditions, there is no conclusive
evidence regarding the effect of HG on birth weight.
Therefore, precise diagnostic criteria for HG should be de-
veloped for use in future investigations.
Conclusions
Our results suggest that neither NVP nor HG affect
birth weight. Despite the methodological limitations of
the study, we believe that these results indicate that
pregnant women need not be concerned about potential
risk for SGA birth due to NVP or HG.










RR 95 % CI RR 95 % CI
Severe NVP 880 48 (5.5) 773 (87.8) 59 (6.7) 0.98 0.75–1.27 0.86 0.62–1.19
No severe NVPa 7563 420 (5.6) 6625 (87.6) 518 (6.8) (1.0) (1.0)
No data on NVP state 188 15 (8.0) 164 (87.2) 9 (4.8)
The crude and adjusted risk ratios calculated using covariates such as the mother’s age, pre-pregnancy body mass index, weight gain during pregnancy, parity,
smoking and alcohol consumption status, education, and income, to determine the effect of severe NVP on the risk of SGA birth
RR risk ratio, CI confidence interval
aUsed as reference in the calculation of risk ratios










RR 95 % CI RR 95 % CI
HG 136 8 (5.9) 119 (87.5) 9 (6.6) 0.97 0.51–1.83 0.81 0.39–1.66
No HGa 6393 331 (5.2) 5622 (87.9) 440 (6.9) (1.0) (1.0)
No data on HG state 2102 144 (6.9) 1821 (86.6) 137 (6.5)
The crude and adjusted risk ratios calculated using covariates such as the mother’s age, pre-pregnancy BMI, weight gain during pregnancy, parity, smoking and al-
cohol consumption status, education, and income, to determine the effect of HG on the risk of SGA birth
RR risk ratio, CI confidence interval
aUsed as reference in the calculation of risk ratios
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